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Abstract
Background: This study assessed lay perceptions of issues related to predictive genetic testing for multifactorial
diseases. These perceived issues may differ from the “classic” issues, e.g. autonomy, discrimination, and
psychological harm that are considered important in predictive testing for monogenic disorders. In this study, type
2 diabetes was used as an example, and perceptions with regard to predictive testing based on DNA test results
and family history assessment were compared.
Methods: Eight focus group interviews were held with 45 individuals aged 35-70 years with (n = 3) and without
(n = 1) a family history of diabetes, mixed groups of these two (n = 2), and diabetes patients (n = 2). All interviews
were transcribed and analysed using Atlas-ti.
Results: Most participants believed in the ability of a predictive test to identify people at risk for diabetes and to
motivate preventive behaviour. Different reasons underlying motivation were considered when comparing DNA test
results and a family history risk assessment. A perceived drawback of DNA testing was that diabetes was considered
not severe enough for this type of risk assessment. In addition, diabetes family history assessment was not
considered useful by some participants, since there are also other risk factors involved, not everyone has a diabetes
family history or knows their family history, and it might have a negative influence on family relations. Respect for
autonomy of individuals was emphasized more with regard to DNA testing than family history assessment. Other
issues such as psychological harm, discrimination, and privacy were only briefly mentioned for both tests.
Conclusion: The results suggest that most participants believe a predictive genetic test could be used in the
prevention of multifactorial disorders, such as diabetes, but indicate points to consider before both these tests are
applied. These considerations differ with regard to the method of assessment (DNA test or obtaining family history)
and also differ from monogenic disorders.
Background
As a result of genomics research, a growing number of
genetic variants that contribute to the multifactorial
aetiology of many common disorders, such as diabetes
and coronary heart disease, are being identified. Multifac-
torial diseases are, however, characterised by complex
gene-environment interactions [1]. Testing based on
these genetic variants alone (DNA-based test), or in
addition to traditional disease risk factors, such as obesity
and hypertension, still shows limited predictive value for
disease [2,3]. While we await the identification of more
genetic variants that do show higher predictive value
together, family history might be used as a ‘genomics’
tool for disease prevention [4]. Numerous studies show
that familial risk is an important and independent risk
factor for multifactorial diseases [5]. Family history
reflects the consequences of a genetic predisposition, a
shared environment, and common behaviour. Family his-
tory information may be used to determine personal dis-
ease risk (family history assessment), raise risk awareness
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and motivate individuals to adopt preventive behaviour
[6]. So far, there is little attention for the use of genetic
information (DNA test results or a family history assess-
ment) in prevention programmes for common diseases
[7]. Nevertheless, new developments in predictive medi-
cine are expected, and this calls for an understanding of
issues related to these tests [8].
Little is known about how people compare and con-
trast predictive testing based on DNA test results to
family history assessment, e.g. in terms of perceived uti-
lity or perceived drawbacks, and how they compare
genetic tests for multifactorial diseases to monogenic dis-
eases. So far, most predictive genetic tests have been
used to detect predispositions for single-gene diseases
with a strong genetic influence, such as hereditary forms
of cancer. For these monogenic diseases there are many
data available on the ethical, legal and social issues of
testing for and communication of genetic risk informa-
tion to individuals and families. Important issues are, for
example, the right (not) to know one’s genetic status [9],
freedom of choice, indicating that free and informed con-
sent has to be guaranteed before a genetic test is carried
out [8], potential genetic discrimination by insurance
companies and employers [10], and privacy issues con-
cerning who has access to sensitive personal genetic
information [11]. Yet, limited research has focused on
the possible ethical, legal and social issues related to
genetic testing for multifactorial diseases [12]. These
issues are expected to be less pronounced, because the
aetiology is essentially different. Each gene variation
might have an effect on more than one disease or pheno-
type, the inheritance of an identical pattern of gene var-
iants is low, and there is a high environmental influence
on the development of a disease [13]. New issues may,
however, arise. For example, Janssens and Khoury [13]
have expressed their concern about whether it is ethical
to perform DNA tests with low predictive value. Other
issues may be relevant for family history assessment. For
example, Yoon et al. [4] suggested that labelling a family
at risk might induce feelings of blame, or induce anxiety
associated with knowledge of affected relatives. More-
over, there is still little evidence about the clinical utility
of DNA testing and family history assessment for multi-
factorial diseases [4,14], i.e. how likely is the test to signif-
icantly improve patient outcomes and motivate people to
engage in preventative behaviour to reduce their disease
risk [15].
In this study we used type 2 diabetes as an example of a
multifactorial disease, and focussed on both DNA test
results and family history assessment to predict the risk
for developing diabetes. Diabetes is an important health
problem, which has an increasing prevalence due to phy-
sical inactivity and unhealthy diet [16]. It has been shown
that modest changes in lifestyle can delay or even prevent
the onset of diabetes in high risk populations [17]. In
addition to behavioural factors, genetic factors also influ-
ence the development of type 2 diabetes [18], but with
limited predictive value [19]. In contrast, a familial risk of
diabetes reflects a 2 to 6-fold increase in the odds of
developing diabetes, depending on the number and close-
ness of affected relatives [20,21].
In order to be able to develop effective prevention
programmes for multifactorial diseases, such as diabetes,
based on genetic risk information, it is important to
explore the opinions and expectations of potential users.
Therefore the aim of this study was to asses lay percep-
tions of issues related to predictive genetic testing (DNA
test results or family history assessment) in diabetes
prevention.
Methods
To gain insight into lay perceptions of predictive testing
for diabetes, focus group interviews were held. Focus
groups aim to promote a variety of opinions and self-
disclosures, i.e. group members influence each other by
responding to comments made by others [22]. The
Medical Ethics Committee of the VU University Medical
Center approved the study protocol.
Participants and procedure
Eight focus group interviews were held with 45 individuals
with (n = 3), and without (n = 1) a family history of dia-
betes, mixed groups of these two (n = 2) and diabetes
patients (n = 2). Participants were recruited by means of
an advertisement in a regional newspaper, inviting people
between 35 and 70 years of age to participate in a group
discussion about the prevention of diabetes. It was indi-
cated that they would receive an incentive of €25 (gift
card) for participation. No further information was pro-
vided. The responders were asked via the telephone
whether they had diabetes, and subsequently whether they
had a first-degree relative with diabetes. Additionally, one
group with a family history of diabetes was recruited
among participants in an earlier diabetes screening study
in 1999 [23]. In that study, participants had been informed
by letter that they did not have diabetes, but no further
information about diabetes prevention was given. The dia-
betes patients were primarily recruited by means of an
advertisement in a magazine distributed by the regional
Diabetes Patient Organisation. All participants gave writ-
ten informed consent before participation.
All the focus groups were facilitated by the same mod-
erator (LH), and an assistant (MWP) made notes during
each session. The focus groups lasted for approximately
90 minutes, and were held at the University Medical Cen-
ter and a community facility between June and October
2008. Since the questions addressed in the focus groups
required some knowledge about the concepts that were
Wijdenes-Pijl et al. BMC Public Health 2011, 11:535
http://www.biomedcentral.com/1471-2458/11/535
Page 2 of 9
referred to, these were briefly explained at the start of the
session using a Powerpoint presentation. The presentation
included information about diabetes, such as causes and
consequences, and information about the difference
between diabetes risk assessment and a blood glucose test
to indicate diabetes. Table 1 shows the information that
was given about the DNA test and the family history
assessment. It was emphasised that the aim of both tests is
to inform people about an increased risk for developing
diabetes and to provide them with preventive options to
reduce the risk, i.e. a healthy diet and physical activity. No
specific risk percentages were given.
A semi-structured interview guide was used to assess
perceptions. The participants were asked to indicate the
possible advantages, disadvantages, and barriers related to
both tests in diabetes prevention. Subsequently, the effect
on individuals and their families (stigmatisation, discrimi-
nation, worry), and privacy issues when using genetic risk
information in diabetes prevention were introduced if the
participants did not bring these subjects up (see Additional
file 1). In addition, two hypothetical vignettes were used to
stimulate discussion. The vignettes described two males
aged 55 years with a high risk of developing diabetes as a
result of: a) two first-degree family members with diabetes
(family history assessment), and b) a positive test result on
a DNA test for diabetes (DNA test). The participants were
asked to indicate which of these two men would be most
or least motivated to adopt healthy behaviour, and why.
Characteristics of the participants in the focus groups
were obtained by means of a brief self-completed ques-
tionnaire (see Table 2).
Preparation of data and analyses
All focus group interviews were audio-taped and tran-
scribed. Atlas-ti software was used for the analyses.
First, codings were annotated to the data to structure
and analyse the transcripts. The codings were then clus-
tered to define sub-themes and main themes. On the
basis of these themes, further analyses were performed
to detect and check correspondence and differences
between the themes, and to search for the most
important messages transmitted by the participants. In
order to ensure uniform coding, two authors (MP and
LH) coded each transcript, and then discussed the cod-
ings until agreement was reached [24]. In the results,
quotations are used to illustrate the meanings that parti-
cipants attached to a theme. Quotations were translated
from Dutch and checked by a Dutch to English transla-
tor. Characteristics of participants are given in brackets,
indicating the type of group (group number (1-3),
general population of people with no family history,
with a family history, mixed group or diabetes patients
(NoFam, Fam, Mix, Pt), [family members with diabetes],
gender (male, female), and age in years).
Results
The most important themes that emerged concerning
predictive genetic testing for diabetes were: 1) identifica-
tion of people at risk, 2) positive and negative health out-
comes, 3) family issues, 4) informational privacy, and 5)
autonomy. These themes and corresponding sub-themes
are shown in Table 3. Perceived differences between test-
ing based on DNA test results and family history assess-
ment will be illustrated.
Identification of people at risk
Participants supported both the use of DNA tests and
family history assessment in order to identify people
who are at risk for diabetes:
If diabetes runs in your family, you don’t assume
that you can get it [diabetes] too. If you have a pre-
disposition for diabetes, because family members are
affected, then I think it is a good idea to promote
such a test [family history assessment], because not
everyone will perceive the risk. (2Mix [nephew],
male, 43 years)
You know it instantly [whether you’re at risk], by
taking some blood. Do I have a predisposition, yes
or no? Brief and effective; it’s [DNA test] a good
test. (1NoFam, female, 53 years)
However, some believed diabetes was not severe
enough for DNA testing:
Genetic testing is [more than for diabetes] for ser-
ious diseases like cystic fibrosis, cancer, kidney dis-
eases. Having a family member with one of these
diseases can be a reason to have a genetic test.
(1Mix [grandmother], female, 69 years)
Participants indicated the advantage that taking a
family history can be done quickly. Others questioned
this assessment, because information about the presence
of diabetes within the family is not always known, it is of
Table 1 Information given to participants during the
focus group sessions concerning both genetic risk
assessments
DNA test Family history assessment
- Risk is increased by genetic
predisposition
- Includes genetic predisposition,
common behaviour, and shared
environment
- Assessed by taking a sample of
blood or saliva
- Risk increases with number and
closeness of affected family
members
- Test result does not depend on
the occurrence of diabetes within
the family
- Assessed by asking about the
number and relatedness of
affected family members
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no use for people without a family history, and there are
other risk factors for diabetes apart from family history:
Having a family member with diabetes implies an
increased risk, but it’s limited, information on
unhealthy living and physical activity should also be
included. (2Mix, female, 52 years)
Some participants emphasised that there should be a
reason for risk assessment to be most effective, i.e. that
people should be at increased risk before having their
risk assessed.
I don’t think that people will think it concerns them.
People will only respond to risk information when
they have physical complaints and only then they
will think “Now I have to be careful.”. (2Fam
[mother], female, 65 years)
Positive and negative health outcomes
Motivation to adopt healthy behaviour
A positive outcome of predictive testing for diabetes that
was mentioned was that it may motivate to engage in
healthy behaviour. Although many participants experi-
enced no difference between DNA test results and family
history assessment in the effect on people’s motivation to
adopt healthy behaviour, some participants believed that
people would be more motivated to adopt risk-reducing
behaviour after having had a DNA test. The underlying
reason they gave was that to have a DNA test is a deliber-
ate decision, since the first step towards risk reduction
has already been taken by having such a test. In addition,
this risk was seen as most certain:
The DNA test gives the hardest ‘push’ to live heal-
thier. It will frighten me more than a test based on a
family history, because it is the strongest evidence.
(1Pt [father, 2 brothers], male, 51 years)
Others believed that familial risk information will
motivate people more than a DNA test to adopt
healthy behaviour, since these people see examples (of
the consequences) of diabetes within their family. The
contrary of enhancing motivation, however, was also
mentioned. Some believed that a family history assess-
ment will not increase the motivation of people with a
familial risk, since these people will already be aware
of the risk. It was also believed that for some people
genetic risk information, based either on DNA or
family history, could reduce motivation. Here an exam-
ple of the adverse impact of family history assessment
is given:
If people are informed that they have a risk, because
their father had diabetes, and their grandfather,
grandmother, and aunt too; it’s discouraging. They
will accept the risk and think they can’t prevent dia-
betes, since it’s heritable. (2Pt, male, 56 years)
Furthermore, some participants mentioned that people
could be falsely reassured if they are told that they have
no genetic risk.
There is a chance that if people hear that they have
no predisposition [for diabetes], that they will think
Table 2 Characteristics of the participants (n = 45) in the focus groups (n = 8)
Group code Average age in
years (SD)
Total Gender Level of education* Family history of diabetes**
Female Low Intermediate High 1st
degree
2nd
degree
None
n n n n n n n n
1NoFam, general population 52 (7) 6 5 0 3 3 0 0 6
1Fam, family history 55 (11) 5 3 0 2 3 4 1 0
2Fam, family history 46 (23) 3 3 0 2 1 2 1 0
3Fam, family history 66 (3) 7 5 5 1 1 6 0 1***
1Mix, mixed group 63 (6) 5 5 1 3 1 1 1 3
2Mix, mixed group 52 (11) 8 6 1 2 5 1 1 6
1Pt, patients 57 (8) 7 5 0 5 2 7 0 0
2Pt, patients 55 (9) 4 2 0 2 2 1 1 2
Total 56 (11) 45 34 7 20 18 22 5 18
* Low level of education refers to people who completed elementary school, lower secondary education or lower vocational education; Intermediate level of
education refers to higher secondary education or intermediate vocational education; High level of education refers to university or higher vocational education
** 1st degree refers to having at least one or more first degree family member(s) with diabetes; 2nd degree refers to having at least one or more second degree
family member(s) with diabetes
*** This person had an extensive family history of people with cardiovascular diseases, but no family members with diabetes.
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“I can eat what I want, being fat is no problem, and
being physically active, I prefer sitting behind the
computer all day.”. (1NoFam, female, 57 years)
Psychological impact
Although some believed that knowing the disease risk
could induce worry, most participants believed that dia-
betes risk assessment, even when genetic risk assessment
is used, would cause very little or no psychological
harm. Moreover the effect on raising risk awareness was
emphasised:
Familial risk information will not necessarily lead to
worry [about disease risk], but it can raise awareness
about the risk. (1Fam [mother, brother], female, 64
years)
Others, however, thought that people might be wor-
ried for and about their children, when family history
will be assessed:
A [familial] risk can be threatening. I’ve got a 14
year-old daughter. If she would be tested [family his-
tory assessment] and hears that she has an increased
risk for diabetes, too, that would be a kind of
“Damocles’ sword” hanging above her head. (1Pt
[mother], female, 50 years)
Family issues
Impact on family relationships
Participants discussed the possible impact of familial
risk information on family relations. On the one hand,
Table 3 Overview of themes raised by participants comparing DNA test results with family history assessment
Themes DNA test Family history assessment Both tests
Identification of people at
risk
Diabetes is not severe
enough
Can be assessed quickly Can identify people at risk
Diabetes family history is unknown Only for high risk individuals
No use for people with no family history
There are other risk factors for diabetes
Positive and negative health
outcomes
Motivation to engage
in healthy behaviour
The test is a deliberate
decision
There is an example of diabetes patients
within the family
Genetic risk cannot be influenced
Risk is certain People with a family history are already
aware of the risk
False reassurance
Psychological impact Worry for and about children Little or no psychological harm
Worry about diabetes risk
Family issues
Influence on
family relationships
Opens family discussion about diabetes and
provides support
Some do not want to be informed, disturbs
family relations
Someone in the family will be blamed
Informing family
members
Obligation to disclose risk information to
family members
Allows to raise children more consciously
Autonomy
Not performed unasked
for
Can be offered to everyone Risk tests should be voluntary
No tests on embryos or
children
Informative before
having children
Informational privacy
Discrimination Discrimination by insurance company or
employer
Sensitive data Ownership of data Private information
No trust in relatively new
test
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some believed that it opens up discussions, and can be
used to support each other to adopt healthy behaviour.
For example, this woman (diabetes is prevalent in her
husband’s family) said:
I think that when you’re aware of diabetes running
in your family, it can help to talk about it with each
other. I notice that the relationships in our family
are not distorted. We talk about it [diabetes in the
family] with each other. Not that we get anxious
about it, but more to be supportive for other family
members. It’s no longer a taboo. (1NoFam, female,
47 years)
On the other hand, some thought that it could also
disturb family relationships if family members do not
want to be informed about their diabetes risk:
My relatives will get anxious [if our family history is
assessed]. [...] There are some who would rather not
know that. So, I think that it can cause anxiety for
some people. (1Mix, female, 57 years)
One participant mentioned that, if family members are
identified to be at risk for diabetes, the patient with dia-
betes in the family might be blamed for putting the
family at risk.
Informing family members
Some diabetes patients felt the obligation to disclose risk
information to other members of the family:
I warned my brother and he visited his general prac-
titioner. He had it, in a less severe way, nevertheless.
So, I think it’s good to warn family members. (1Pt,
[father, mother, brother, uncle, aunt], male, 63 years)
Another issue was that participants, diabetes patients
in particular, did not only see the benefit of genetic risk
information for themselves, but indicated that knowing
their risk will also allow people to raise their children
more consciously:
[DNA test results] can be used preventatively, if I
know that my little son might be at risk I can be
careful about his diet. (2Pt [father, grandmother],
female, 46 years)
Autonomy
Issues that would affect autonomy were emphasised
more when the DNA test was discussed. While most
participants believed that DNA tests should never be
performed (or even offered) unless asked for, no such
condition was suggested with regard to a family history
assessment. Moreover, only one participant mentioned
that having a family history assessment should be volun-
tary. For this test it was even suggested that it should be
actively offered to the entire population:
Why are we never approached for such a test [family
history assessment]? Now, people themselves must
request it, but they don’t go to the doctor for such a
thing. [...] So, I think that the government should
provide the test.
Moreover, one woman also mentioned that DNA tests
should not be performed on embryos or children, possi-
bly referring to the fact that they are not able to properly
consent:
They might test [DNA test] young children, and they
may even test embryos [...] there is a high risk that
they will go further, and one thing may lead to
another. (1Fam [mother], female, 58 years)
Another person mentioned that a DNA test could be
informative before having children, suggesting that it
can be used before conception to give an indication of a
possible genetic predisposition for diabetes in the off-
spring, and thus as a means to reproductive autonomy:
For example, for young people who would like to
have children, and diabetes is very common in their
family. I think it’s a good thing that they can have a
genetic test. (2Fam [mother], female, 65 years)
Informational privacy
Discrimination
Only one participant indicated that a consequence of a
genetic test might be discrimination on the basis of the
test results:
How will the [family history] information be used?
Now it’s voluntary to provide the information, but
these tests may be obligatory in the future. Then
you have the risk that people will be unable to get
insurance; life insurance and that sort of thing.
(3Fam, female, 61 years)
This woman therefore argued that family information
should be protected from third parties. Subsequently this
belief was picked up and supported by other participants.
Sensitive data
Two participants worried about the safety of the data-
storage of DNA test results (ownership of data):
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I can imagine that your whole genetic profile will
then be public...I think it should be stored some-
where safe. When it’s stored with the general practi-
tioner, there is at least some privacy. (2Mix, female,
49 years)
In addition, some did not trust DNA test results,
because it is a relatively new test:
If they want to prove that someone is at risk, they
can manipulate the results. I don’t know how, since
it’s quite new, quite precarious. (1Mix [grand-
mother], female, 69 years)
With regard to a family history assessment, a diabetes
patient indicated that discussing the presence of diabetes
in the family can be considered as private information:
You can get a problem with privacy. When you say
my brother has diabetes and my sister has diabetes,
and she’s too fat, then you say things about your
family that are personal, and some people might
have a problem with that. (1Pt, male, 51 years)
Discussion
This study provides an overview of perceived issues that
may arise among the public when predictive tests for dia-
betes, based either on DNA test results or family history
assessment, are introduced. Although it was believed that
both tests could be used to identify people at risk for dia-
betes, also drawbacks were mentioned. With regard to
the motivational impact, participants perceived differ-
ences in the underlying mechanism between a DNA test
and family history assessment and both arguments for a
positive and a negative impact were mentioned. Respect
for autonomy of individuals was emphasized more with
regard to DNA testing than family history assessment.
Psychological harm, and discrimination, privacy were
only mentioned by some participants.
Participants had high expectations about the predictive
value of DNA test results. However, until now genetic var-
iants have a marginal improvement in predictive ability
above traditional risk factors for diabetes [2,19]. Also,
some participants had an unrealistic perception of the pos-
sible uses of DNA test results, e.g. they believed that the
test result can be manipulated, or believed that informa-
tion about a genetic risk for diabetes could be used to
make a reproductive choice. Earlier studies have shown
that many people know little about genetic technology,
and have unclear notions about the benefit of genetic test-
ing for multifactorial diseases, but are interested in having
these tests [25]. For example, it has been shown that non-
diabetic patients were more likely to request a genetic test
to assess future diabetes risk than physicians were to
recommend it, and also had higher beliefs that it will moti-
vate people to adopt healthy behaviour [26].
Although the participants believed that both assess-
ments could be used to identify high risk individuals,
some thought that diabetes was not severe enough for a
DNA test. People in general perceive diabetes as less
threatening than other common diseases such as cancer
or heart disease [27]. Other participants in this study
questioned the accuracy and reliability of family history
reports, since the presence of diabetes in the family is
not always known. An under-reporting of the family his-
tory of common chronic diseases for parents and sib-
lings has, indeed, been found in several studies [28].
Participants gave several underlying reasons for the moti-
vational impact of either a DNA test or a family history
assessment, and these differed between both tests. Some
believed that people would get more motivated after
receiving DNA test results, since a first step has already
been made by taking such a test and the test result is con-
sidered more certain as compared with a family history
test. The perception that a diabetes risk based on DNA test
results is more concretely defined and based on evidence
has previously been identified among people at risk for get-
ting diabetes [29]. With regard to family history assess-
ment, participants in this study mentioned that having
examples of diabetes patients within the family will moti-
vate people to engage in preventive behaviour. Research
has shown that the perceived difference in impact of
genetically-based risk information or family history-based
risk information on motivation (or intention) to engage in
recommended health behaviour is inconsistent [30,31].
Only few studies evaluated the impact of genetic risk infor-
mation on motivation (or intention) to adopt healthy beha-
viour and report conflicting effects on actual behaviour
change [13,32]. Some participants in this study believed
that genetic risk information could lead to fatalism, i.e.
people being less motivated to change their behaviour.
However, there is no evidence for such an effect [33].
In the present study, no prominent distinctions were
found between the opinions of people with a family his-
tory of diabetes, people without a family history of dia-
betes, and diabetes patients. It seemed, however, that
diabetes patients perceived more benefits of genetic risk
information for their children compared to the other par-
ticipants, and also felt obliged to disclose risk information
to other members of the family. Also, participants men-
tioned that familial risk information can support family
members to jointly adopt preventative behaviour. It has
indeed been shown that healthy eating habits may be
easier to achieve if the entire family is involved in pro-
moting healthy living [34].
Participants placed more emphasis on autonomy with
regard to the unrequested offer of a DNA-test, as they
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do not want to be offered such a test unless asked for,
whereas this was not brought up as a condition with
regard to a family history assessment. Moreover, with
regard to a family history assessment, only one person
indicated that it will be important to be able to accept
or reject the test, thus stressing that participation should
be voluntary. In general, we conclude that being offered
a family history test was far less readily considered as a
potential threat to autonomy than the offer of a DNA-
test. Therefore, the former type of assessment might be
more ready for a public health setting, as has been sug-
gested by others [4,6]. Khoury [35] indicated that with
the output of the human genome project there has been
a shift from gene-assessment for individuals or families
(monogenic disorders) to a public health approach (mul-
tifactorial diseases). While genetics has traditionally
focused on a non-directive way of communicating infor-
mation to diagnose and manage rare conditions for
which there might not be effective interventions [36].
Type 2 diabetes is very common and people can reduce
their risk for the disease by adopting healthy behaviour.
This may justify a public health approach, i.e. offering a
family history risk assessment and health messages to
people who did not ask for it. Indeed, the issues men-
tioned by the participants in the present study are com-
parable to non-genetic risk assessment and related to
issues that are specifically relevant in public health.
In this explorative study, issues related to monogenic
diseases, such as discrimination, privacy, and psychologi-
cal impact, were mentioned by only few participants; for
example, the possibility of discrimination by insurance
company or employer based on genetic test results, priv-
acy or induced worry. A reason for this might be that the
views of people, as far as they are familiar with genetic
risks, may be influenced by discussions about genetic
testing for monogenic disorders. It is, however, expected
that issues concerning, for example, diabetes risk worry
and discrimination, might be less applicable for multifac-
torial diseases than for monogenic disorders [12], because
of the preventive options that are available. In a review
on the delivery of genomic medicine for common chronic
diseases it was concluded that there are no well-docu-
mented cases of health insurers either asking for or using
genetic test results for discriminative purposes [25].
However, even with existing legislation the fear of genetic
discrimination with regard to testing for adult-onset dis-
eases has not greatly reduced [37].
The findings presented in this paper are not intended
to be generalised, rather they give an overview of possi-
ble issues related to genetic risk assessment for diabetes
as perceived by participants. It can be expected that
people who are more interested in health or who are in
need of money are more prone to have responded on
the study invitation. Besides, more women than men
participated in this study, which may have influenced
the findings as it has been shown that women, in gen-
eral, are less favourable towards genetic testing than
men [38,39]. A drawback in the discussions may have
been that the current low predictive value of DNA test
results was not explained to the participants, since this
information was considered to be too complex. More-
over, because of the semi-structured interview guide, the
issues that were raised by the participants were also
more or less the issues that were addressed during the
interviews. Monogenic sub-types of diabetes, such as
Maturity Onset Diabetes of the young (MODY), were
not considered. The predictive value of genetic testing
for these rare sub-types is clearly higher.
Conclusions
The results of this study indicate that individuals believe
in the ability of predictive genetic testing to identify
people at diabetic risk and enhancing healthy behaviour,
but also points to consider before using these tests were
identified. With regard to DNA tests these are, e.g. an
unrealistic perception of the test results, and a perceived
threat for autonomy. It is therefore important to educate
people about DNA tests for multifactorial diseases and
to inform possible future consumers about the low pre-
dictive value, as was also recommended by the European
Society of Human Genetics [11]. With regard to the
family history assessment, participants indicated draw-
backs in identifying people at risk and a possible nega-
tive influence on family relations. The results further
show that issues that are important in testing for mono-
genic diseases, such as privacy, discrimination, and psy-
chological harm, are mentioned by some participants
with regard to this multifactorial disease. Nevertheless,
new issues will most likely become important, which are
more related to a public health setting and non-genetic
risk information.
Additional material
Additional file 1: Interview guide for the focus groups. Semi-
structured interview guide and vignettes that were used during the
focus group interviews with the lay participants.
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